Pierre Legault CPA serves as
Independent Director of the Company. Mr. Legault also serves on the board of Artios Pharma (Chairman), Bicycle Therapeutics (Chairman), Poxel Pharmaceuticals (Chairman), Clementia Pharmaceuticals and Urovant Sciences. Previously, he served on the board of Armo BioSciences, Iroko Pharmaceuticals, Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Cyclacel Pharmaceuticals, Eckerd Pharmacy, Regado Biosciences, NephroGenex and several others. Mr. Legault served as Chairman of NephroGenex, a biopharmaceutical company, from 2012 through 2013, and as Chief Executive Officer from 2014 through 2016, as Chief Executive Officer of Prosidion from 2010 through 2012, and Executive Vice President, Chief Financial Officer, and Treasurer of OSI Pharmaceuticals from 2009 through 2010. His prior senior executive experience also includes serving as President of Eckerd Pharmacy and as Executive Vice President and Chief Administrative Officer of Rite Aid Corporation. He also held several senior positions with Sanofi-Aventis and predecessor companies, including President of Worldwide Dermatology Operations. Mr. Legault studied at McGill University, HEC Montreal and Harvard Business School. He holds an M.B.A., BAA, CA, CPA and Six Sigma Green Belt diplomas.
What is Pierre Legault's net worth?
The estimated net worth of Pierre Legault is at least $640,320.00 as of January 12th, 2023. Legault owns 32,000 shares of Bicycle Therapeutics stock worth more than $640,320 as of December 3rd. This net worth estimate does not reflect any other assets that Legault may own. Learn More about Pierre Legault's net worth.
How do I contact Pierre Legault?
Has Pierre Legault been buying or selling shares of Bicycle Therapeutics?
Pierre Legault has not been actively trading shares of Bicycle Therapeutics during the last quarter. Most recently, Pierre Legault sold 44,537 shares of the business's stock in a transaction on Tuesday, December 21st. The shares were sold at an average price of $57.11, for a transaction totalling $2,543,508.07. Learn More on Pierre Legault's trading history.
Who are Bicycle Therapeutics' active insiders?
Are insiders buying or selling shares of Bicycle Therapeutics?
In the last twelve months, insiders at the sold shares 17 times. They sold a total of 32,657 shares worth more than $683,852.68. The most recent insider tranaction occured on November, 11th when CAO Travis Alvin Thompson sold 6,256 shares worth more than $157,088.16. Insiders at Bicycle Therapeutics own 8.5% of the company.
Learn More about insider trades at Bicycle Therapeutics. Information on this page was last updated on 11/11/2024.
